Background Gastrectomy remains a major surgery that may result in significant deterioration of the patient's health-related quality of life (QOL). This study assessed differences in short- and long-term QOL among patients following Totally Laparoscopic Proximal Gastrectomy with Double-Tract reconstruction (TLPG-DT) in comparison to those of Totally Laparoscopic Total Gastrectomy (TLTG). Methods Patients with gastric cancer who underwent totally laparoscopic proximal and total gastrectomy in the Department of General Surgery, Huashan Hospital, Fudan University, from January 2015 to January 2020 were collected and retrospectively analyzed. Participants completed the EORTC cancer (QLQ-C30) and gastric (QLQ-STO22) questionnaires less than six months after surgery and more than one year after surgery. Results There were 25 patients who underwent TLPG-DT and 30 patients who underwent TLTG. For short-term outcomes, TLPG-DT patients had worse social function (p-value = 0.014), appetite (p-value = 0.038), and anxiety (p-value = 0.004) than TLTG patients. As for long-term outcomes, patients in both groups had similar quality-of-life scores. Patients in the TLPG-DT group had higher albumin and hemoglobin levels, as well as more time and cost for the procedure (paid ¥8,713 and ¥1,271 more than patients in the TLTG group in terms of total cost and consumables cost, respectively). There was no difference in complications and OS between the two groups. Conclusions The short-term QOL of TLPG-DT patients was inferior to that of TLTG patients, while there was no significant difference in the long-term QOL between them. TLPG-DT had a satisfactory QOL, which, combined with the better nutritional status of this group of patients after surgery, warrants replication in established surgical centers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.